Developer docs
API playgroundTry for free, no card

Search company profiles

CheqUp

Full company profile

uuid00086r7

Namestring
CheqUp
Legal namestring
CheqUp Health Limited
Websiteurl
chequp.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

CheqUp Health Limited is a UK-based digital health platform, founded in 2020 and headquartered in Chippenham, Wiltshire, that delivers clinician-led online weight loss programmes combining prescription GLP-1 medications (Mounjaro/tirzepatide, Wegovy/semaglutide, and forthcoming oral GLP-1 treatments) with unlimited 1:1 health coaching and WeightWatchers app integration. The core product is the CheqUp Weight Loss Programme: customers complete an online medical questionnaire, undergo Persona-based identity verification, receive clinical assessment by CQC-registered prescribers, and are subscribed to a monthly medication delivery programme with cold-chain packaging, supported by qualified nutritionist and personal trainer health coaches. The platform holds CQC, GPhC, NHS DTAC, NICE recommended supplier, Cyber Essentials, DSPT, and LegitScript certifications, and dispenses medications either through its own GPhC-registered pharmacy or CloudRx as an alternative.

The business operates as a direct-to-consumer subscription model priced from £109/month, with rolling monthly, 3-month, and 6-month commitment tiers (the latter two at discounted rates with a £50 early-cancellation fee). Revenue also includes one-time supplement sales and a forthcoming Maintenance Programme for post-treatment retention. Distribution combines the CheqUp DTC website with two-way referral partnerships signed in June 2026 — Weight Watchers (giving UK WW members access to CheqUp consultations) and Bluecrest Wellness (referring at-risk patients from Bluecrest's 1.3M+ completed health assessments). CheqUp served 60,000+ UK members as of June 2026. The GTM motion is digital-first with a lean team of 11-50 employees, leveraging outsourced clinical labour, third-party identity verification, and the WeightWatchers content library for behavioural support.

Short descriptiontext

CheqUp Health Limited is a UK-based digital health platform providing clinician-led online weight loss programmes that combine prescription GLP-1 medications with unlimited 1:1 health coaching and WeightWatchers app integration for individual UK adults seeking medical obesity treatment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
weight loss treatment, online medical consultations, GLP-1 medications, prescription weight management, digital health platform
Industry1 code
1Pharmacy Benefit Management (PBM) & Formulary Management IT
CodeHLACAKADPrimaryYes
NAICS code3 codes
  • Diet and Weight Reducing Centers812191
  • Food (Health) Supplement Retailers456191
  • Pharmacies and Drug Retailers456110
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Online Weight Management Services
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Prescription Weight Loss Medication Subscription
TypeSubscription Recurring
Description

Monthly recurring subscription programme for prescription weight loss medications including Mounjaro and Wegovy. Customers pay an initial payment followed by recurring monthly payments in advance. Injectable treatments run on a 28-day cycle; oral treatments on a 30-day cycle.

chequp.com
2Commitment Plans
TypeSubscription Recurring
Description

Discounted pricing for 3 Month Plan and 6 Month Plan commitment terms, with discounted prices locked in for the duration of the commitment. Early cancellation triggers a £50 administration fee.

chequp.com
3Supplements and Non-Prescription Products
TypeOne Time License
Description

One-time purchases of vitamins and supplements to support wellbeing, sold as standalone products not requiring clinical assessment.

chequp.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details4 tiers
1Programme starting price
ModelSubscriptionBilling cadenceMonthly
Notes

Clinician-Led Online Weight Loss Programme from £109

chequp.com
23 Month Commitment Plan
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Discounted pricing for 3-month commitment with lower monthly rate. Early cancellation fee of £50 applies if cancelled before completing the term.

chequp.com
36 Month Commitment Plan
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Discounted pricing for 6-month commitment with lowest monthly rate. Early cancellation fee of £50 applies if cancelled before completing the term.

chequp.com
4Rolling Monthly Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Month-to-month subscription with flexibility to pause or cancel at any time. Can be paused indefinitely.

chequp.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CheqUp is a UK digital weight health platform that sells a clinician-led online weight loss programme combining prescription GLP-1 medications (Mounjaro, Wegovy, and forthcoming oral GLP-1 treatments) with unlimited 1:1 health coaching from qualified Nutritionists and Personal Trainers, NICE-aligned clinical eligibility screening, and complimentary access to the WeightWatchers tracking app and GLP-1 Companion Programme. Prescriptions are issued by CQC-registered prescribers and dispensed by CheqUp Health Limited, a GPhC-registered pharmacy, with medications delivered in temperature-monitored cold-chain packaging. The all-inclusive subscription also covers supplements, follow-on maintenance, and partnership-based channels via Weight Watchers and Bluecrest Wellness.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 35% more weight loss when using Health Coach and tracking app vs going alone
+3 more records
Product overview1 text field

CheqUp operates as a unified digital weight health platform combining prescription GLP-1 medications with behavioural support. The core offering is the CheqUp Weight Loss Programme, which integrates clinician-led medical treatment (including Mounjaro, Wegovy injectables, and the upcoming Wegovy Pill and Orforglipron oral tablets) with unlimited 1:1 Health Coaching and the WeightWatchers app. All CheqUp members receive complimentary access to the WeightWatchers GLP-1 Companion Programme for daily accountability. Additional offerings include weight loss supplements and a maintenance programme for long-term weight management. The platform is registered with the Care Quality Commission and General Pharmaceutical Council, requiring medical questionnaires, identity verification (via Persona), and photo proof of weight for prescribing.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-16
Description

Expanded partnership announced June 16, 2026 creating a two-way integration. Weight Watchers members in the UK can access CheqUp consultations and medical weight loss programmes through the Weight Watchers website. CheqUp members receive full access to the Weight Watchers app and GLP-1 Companion Programme including Core+ programme and personalised nutrition, medication tracking, strength and community accountability support. Partnership builds on initial 2025 collaboration and mirrors the integrated clinical model Weight Watchers offers in the US.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-10
Description

Partnership announced June 10, 2026 linking Bluecrest health assessments with CheqUp's clinically supported weight health programmes. Bluecrest customers identified as at risk of weight-related health conditions can be referred directly into CheqUp's programme with access to expert guidance, a dedicated Health Coach, and evidence-based approach. CheqUp members can take up Bluecrest health assessments to build a clearer picture of their health and track improvements in blood markers and body composition. Bluecrest has completed over 1.3 million health assessments across more than 400 locations nationwide.

Strategic tierCoreTypeTechnology or Integration
Description

Third-party identity verification provider used to verify patient identity and perform liveness and fraud-prevention checks as part of CheqUp's prescribing and pharmacy services. Collects biometric data (scan of facial geometry) with explicit user consent.

4Menoclinic
Strategic tierMinorTypeGTM or Marketing Partner
Description

Recommended specialist menopause partner who can help with 1:1 treatment solutions. CheqUp refers members to Menoclinic for personalised menopause care.

chequp.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based digital health platform offering prescription treatments (including weight-loss and men's health) via online consultation, clinician prescribing, and direct-to-patient dispensing. Closely comparable to CheqUp in geography, regulatory positioning, and D2C subscription model.

TypeDirect peer
Description

UK/European online clinic providing remote consultations and prescription medications, including weight management, with CQC-registered clinicians. Directly comparable to CheqUp as a multi-vertical D2C telehealth prescriber operating in the UK market.

TypeDirect peer
Description

UK digital weight-loss platform delivering prescription medication alongside habit-change programmes. Highly comparable to CheqUp's integrated medical-plus-behavioural model and target customer (UK adults seeking medical weight loss).

TypeBroad incumbent
Description

Online clinic service operated by the UK's largest pharmacy chain, offering prescription weight-loss treatment with in-person pharmacy backup. Comparable to CheqUp in product and target customer, with a much larger incumbent brand and physical footprint.

TypeDirect peer
Description

UK digital health company providing clinician-led weight-loss treatment including GLP-1 medications via an online prescribing pathway. Comparable to CheqUp in product mix, target segment, and regulatory approach.

TypeOthers
Description

Global behavioural weight-loss brand and CheqUp's core UK strategic partner, offering the integrated WeightWatchers app/GLP-1 Companion Programme that CheqUp bundles. Adjacent rather than direct competitor — CheqUp provides the prescribing arm that complements WW's behavioural programme.

TypeDirect peer
Description

UK digital weight-management programme pairing behavioural support with clinical pathways (including NHS partnerships) for medical weight loss. Directly comparable to CheqUp's integrated coaching-and-medication model and UK regulatory positioning.

8Ro
TypeBroad incumbent
Description

US-based direct-to-patient healthcare platform operating an online clinic and pharmacy with a growing weight-loss offering. Comparable to CheqUp as a D2C digital prescriber of GLP-1 medications with vertically integrated pharmacy.

TypeBroad incumbent
Description

US-listed multi-vertical D2C telehealth platform that has expanded into GLP-1-based weight loss. Comparable to CheqUp in D2C subscription prescribing of GLP-1s, with a far larger scale and broader product portfolio.

TypeDirect peer
Description

UK D2C health platform offering prescription treatments across men's health and weight management via online consultation and home delivery. Comparable to CheqUp in subscription prescribing model and UK-only digital clinic structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CheqUp

Online Weight Management Serviceschequp.com

CheqUp Health Limited is a UK-based digital health platform providing clinician-led online weight loss programmes that combine prescription GLP-1 medications with unlimited 1:1 health coaching and WeightWatchers app integration for individual UK adults seeking medical obesity treatment.

What CheqUp does

CheqUp Health Limited is a UK-based digital health platform, founded in 2020 and headquartered in Chippenham, Wiltshire, that delivers clinician-led online weight loss programmes combining prescription GLP-1 medications (Mounjaro/tirzepatide, Wegovy/semaglutide, and forthcoming oral GLP-1 treatments) with unlimited 1:1 health coaching and WeightWatchers app integration. The core product is the CheqUp Weight Loss Programme: customers complete an online medical questionnaire, undergo Persona-based identity verification, receive clinical assessment by CQC-registered prescribers, and are subscribed to a monthly medication delivery programme with cold-chain packaging, supported by qualified nutritionist and personal trainer health coaches. The platform holds CQC, GPhC, NHS DTAC, NICE recommended supplier, Cyber Essentials, DSPT, and LegitScript certifications, and dispenses medications either through its own GPhC-registered pharmacy or CloudRx as an alternative.

The business operates as a direct-to-consumer subscription model priced from £109/month, with rolling monthly, 3-month, and 6-month commitment tiers (the latter two at discounted rates with a £50 early-cancellation fee). Revenue also includes one-time supplement sales and a forthcoming Maintenance Programme for post-treatment retention. Distribution combines the CheqUp DTC website with two-way referral partnerships signed in June 2026 — Weight Watchers (giving UK WW members access to CheqUp consultations) and Bluecrest Wellness (referring at-risk patients from Bluecrest's 1.3M+ completed health assessments). CheqUp served 60,000+ UK members as of June 2026. The GTM motion is digital-first with a lean team of 11-50 employees, leveraging outsourced clinical labour, third-party identity verification, and the WeightWatchers content library for behavioural support.

CheqUp firmographics

Firmographics
Name
CheqUp
Legal name
CheqUp Health Limited
Website
https://chequp.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
CheqUp Health Limited is a UK-based digital health platform providing clinician-led online weight loss programmes that combine prescription GLP-1 medications with unlimited 1:1 health coaching and WeightWatchers app integration for individual UK adults seeking medical obesity treatment.
Ownership category
akta.pro rank

CheqUp industry classification

Industry
Product category
Online Weight Management Services
NAICS
Diet and Weight Reducing Centers (812191), Food (Health) Supplement Retailers (456191), Pharmacies and Drug Retailers (456110)
SIC
Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry
Pharmacy Benefit Management (PBM) & Formulary Management IT (HLACAKAD)

Keywords

  • Weight loss treatment
  • Online medical consultations
  • GLP-1 medications
  • Prescription weight management
  • Digital health platform

Where CheqUp is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

CheqUp business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Prescription Weight Loss Medication Subscription: Monthly recurring subscription programme for prescription weight loss medications including Mounjaro and Wegovy. Customers pay an initial payment followed by recurring monthly payments in advance. Injectable treatments run on a 28-day cycle; oral treatments on a 30-day cycle.
  2. Commitment Plans: Discounted pricing for 3 Month Plan and 6 Month Plan commitment terms, with discounted prices locked in for the duration of the commitment. Early cancellation triggers a £50 administration fee.
  3. Supplements and Non-Prescription Products: One-time purchases of vitamins and supplements to support wellbeing, sold as standalone products not requiring clinical assessment.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyProgramme starting price
SubscriptionMulti-year contract3 Month Commitment Plan
SubscriptionMulti-year contract6 Month Commitment Plan
SubscriptionMonthlyRolling Monthly Subscription

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

CheqUp product offering

Product offering

Core offering

CheqUp is a UK digital weight health platform that sells a clinician-led online weight loss programme combining prescription GLP-1 medications (Mounjaro, Wegovy, and forthcoming oral GLP-1 treatments) with unlimited 1:1 health coaching from qualified Nutritionists and Personal Trainers, NICE-aligned clinical eligibility screening, and complimentary access to the WeightWatchers tracking app and GLP-1 Companion Programme. Prescriptions are issued by CQC-registered prescribers and dispensed by CheqUp Health Limited, a GPhC-registered pharmacy, with medications delivered in temperature-monitored cold-chain packaging. The all-inclusive subscription also covers supplements, follow-on maintenance, and partnership-based channels via Weight Watchers and Bluecrest Wellness.

Product overview

CheqUp operates as a unified digital weight health platform combining prescription GLP-1 medications with behavioural support. The core offering is the CheqUp Weight Loss Programme, which integrates clinician-led medical treatment (including Mounjaro, Wegovy injectables, and the upcoming Wegovy Pill and Orforglipron oral tablets) with unlimited 1:1 Health Coaching and the WeightWatchers app. All CheqUp members receive complimentary access to the WeightWatchers GLP-1 Companion Programme for daily accountability. Additional offerings include weight loss supplements and a maintenance programme for long-term weight management. The platform is registered with the Care Quality Commission and General Pharmaceutical Council, requiring medical questionnaires, identity verification (via Persona), and photo proof of weight for prescribing.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 35% more weight loss when using Health Coach and tracking app vs going alone
  • +3 more outcomes

Companies that use CheqUp

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

CheqUp technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

CheqUp partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Weight Watchers (WW International, Inc.)coreStrategic or Co-development Partner · 16 June 2026Expanded partnership announced June 16, 2026 creating a two-way integration. Weight Watchers members in the UK can access CheqUp consultations and medical weight loss programmes through the Weight Watchers website. CheqUp members receive full access to the Weight Watchers app and GLP-1 Companion Programme including Core+ programme and personalised nutrition, medication tracking, strength and community accountability support. Partnership builds on initial 2025 collaboration and mirrors the integrated clinical model Weight Watchers offers in the US.
  • Bluecrest WellnesscoreStrategic or Co-development Partner · 10 June 2026Partnership announced June 10, 2026 linking Bluecrest health assessments with CheqUp's clinically supported weight health programmes. Bluecrest customers identified as at risk of weight-related health conditions can be referred directly into CheqUp's programme with access to expert guidance, a dedicated Health Coach, and evidence-based approach. CheqUp members can take up Bluecrest health assessments to build a clearer picture of their health and track improvements in blood markers and body composition. Bluecrest has completed over 1.3 million health assessments across more than 400 locations nationwide.
  • Persona Identities, Inc.coreTechnology or IntegrationThird-party identity verification provider used to verify patient identity and perform liveness and fraud-prevention checks as part of CheqUp's prescribing and pharmacy services. Collects biometric data (scan of facial geometry) with explicit user consent.
  • MenoclinicminorGTM or Marketing PartnerRecommended specialist menopause partner who can help with 1:1 treatment solutions. CheqUp refers members to Menoclinic for personalised menopause care.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

CheqUp competitors and assessment

Company assessment

Direct peers

  • Numan: UK-based digital health platform offering prescription treatments (including weight-loss and men's health) via online consultation, clinician prescribing, and direct-to-patient dispensing. Closely comparable to CheqUp in geography, regulatory positioning, and D2C subscription model.
  • Zava: UK/European online clinic providing remote consultations and prescription medications, including weight management, with CQC-registered clinicians. Directly comparable to CheqUp as a multi-vertical D2C telehealth prescriber operating in the UK market.
  • Habitual: UK digital weight-loss platform delivering prescription medication alongside habit-change programmes. Highly comparable to CheqUp's integrated medical-plus-behavioural model and target customer (UK adults seeking medical weight loss).
  • Voy: UK digital health company providing clinician-led weight-loss treatment including GLP-1 medications via an online prescribing pathway. Comparable to CheqUp in product mix, target segment, and regulatory approach.
  • Second Nature: UK digital weight-management programme pairing behavioural support with clinical pathways (including NHS partnerships) for medical weight loss. Directly comparable to CheqUp's integrated coaching-and-medication model and UK regulatory positioning.
  • Manual: UK D2C health platform offering prescription treatments across men's health and weight management via online consultation and home delivery. Comparable to CheqUp in subscription prescribing model and UK-only digital clinic structure.

Broad incumbents

  • Boots Online Doctor: Online clinic service operated by the UK's largest pharmacy chain, offering prescription weight-loss treatment with in-person pharmacy backup. Comparable to CheqUp in product and target customer, with a much larger incumbent brand and physical footprint.
  • Ro: US-based direct-to-patient healthcare platform operating an online clinic and pharmacy with a growing weight-loss offering. Comparable to CheqUp as a D2C digital prescriber of GLP-1 medications with vertically integrated pharmacy.
  • Hims & Hers Health: US-listed multi-vertical D2C telehealth platform that has expanded into GLP-1-based weight loss. Comparable to CheqUp in D2C subscription prescribing of GLP-1s, with a far larger scale and broader product portfolio.

Others

  • Weight Watchers (WW International): Global behavioural weight-loss brand and CheqUp's core UK strategic partner, offering the integrated WeightWatchers app/GLP-1 Companion Programme that CheqUp bundles. Adjacent rather than direct competitor — CheqUp provides the prescribing arm that complements WW's behavioural programme.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

CheqUp social profiles

Digital presence

CheqUp compliance and trust

Trust signal

Compliance8 records

CheqUp financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CheqUp leadership team

Management profile

Number of profiles

Profiles3 records

CheqUp funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CheqUp M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CheqUp

What does CheqUp do?

CheqUp is a UK digital weight health platform that sells a clinician-led online weight loss programme combining prescription GLP-1 medications (Mounjaro, Wegovy, and forthcoming oral GLP-1 treatments) with unlimited 1:1 health coaching from qualified Nutritionists and Personal Trainers, NICE-aligned clinical eligibility screening, and complimentary access to the WeightWatchers tracking app and GLP-1 Companion Programme. Prescriptions are issued by CQC-registered prescribers and dispensed by CheqUp Health Limited, a GPhC-registered pharmacy, with medications delivered in temperature-monitored cold-chain packaging. The all-inclusive subscription also covers supplements, follow-on maintenance, and partnership-based channels via Weight Watchers and Bluecrest Wellness.

Is CheqUp a public or private company?

CheqUp is a private company. It is classified as unknown and is currently operating.

When was CheqUp founded?

CheqUp was founded in 2020. It employs 11 to 50 people.

Where is CheqUp based?

CheqUp is headquartered in London, United Kingdom, in the Europe region.

How does CheqUp make money?

Three revenue lines are on record. Prescription Weight Loss Medication Subscription is the primary driver. The others are commitment Plans and supplements and Non-Prescription Products.

Who are CheqUp's main competitors?

Direct peers on record are Numan, Zava, Habitual, Voy, Second Nature and Manual. Broad incumbents are Boots Online Doctor, Ro and Hims & Hers Health. Weight Watchers (WW International) is listed as an others.

Does CheqUp have an API?

No public API is recorded for CheqUp.

What industry is CheqUp in?

CheqUp's product category is Online Weight Management Services. Its primary akta.pro industry code is HLACAKAD, Pharmacy Benefit Management (PBM) & Formulary Management IT. Its NAICS code is 812191 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Pharma Letter350% rise in demand for daily Wegovy weight-loss pillDanish pharma company Novo Nordisk launched its daily Wegovy Pill (semaglutide) in the UK, and three weeks post-launch, weight health provider CheqUp reports a 350% rise in demand for the oral weight-loss medication. The strong early uptake signals consumer interest in a clinically supported oral alternative to injectable weight-loss treatments. As awareness grows that oral semaglutide may be a viable option for eligible patients, demand continues to build.Daily RecordExpert warning over new weight loss pills as they roll out across UKThe Wegovy weight-loss pill, containing semaglutide, has become available for private purchase from UK pharmacies and online providers, making it the first pill of its kind approved by the Medicines and Healthcare products Regulatory Agency (MHRA). Medical experts at treatment provider CheqUp have warned against using the medication as a quick fix, emphasizing that success requires gradual dose titration, consistent use, clinical oversight, and pairing medication with lifestyle changes. The tablet differs from the injection in that it must be taken every morning on an empty stomach with a 30-minute wait before eating or taking other medications.Daily RecordWegovy weight loss pill 'meaningful difference' tip if you are going on holidayThe new oral pill version of Wegovy (semaglutide) weight loss medication has been approved by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and is now available privately from pharmacies and online vendors, though it has yet to be approved for NHS use. Treatment provider CheqUp highlights that unlike injectable GLP-1 treatments requiring refrigeration, the pill is stored at room temperature, making it significantly more convenient for frequent travellers. A CheqUp survey found that 50 per cent of 1,000 respondents using injectable weight-loss medications had to change, delay, or cancel trips due to injection management concerns.Daily RecordWegovy weight loss pill warning as you must follow 30-minute ruleA new oral version of the Wegovy weight loss medication has launched in the UK for private purchase at pharmacies, becoming the first pill of its kind to receive MHRA approval. Medical experts from treatment provider CheqUp have advised that the pill must be taken every morning on an empty stomach with up to 120ml of water, followed by a mandatory 30-minute wait before eating, drinking anything other than water, or taking other medications. Patients switching from Wegovy injections should allow a 7-day gap between their last injection and first tablet, with some experiencing temporary increased appetite or indigestion during the transition period.Investing.comWeight Watchers expands CheqUp partnership in the UK By Investing.comWW International Inc (Weight Watchers) announced an expansion of its partnership with UK digital weight health platform CheqUp, enabling Weight Watchers members in the UK to access CheqUp consultations and medical weight loss programs through the Weight Watchers website, while CheqUp members receive access to the Weight Watchers app and GLP-1 Companion Programme. The expanded partnership builds on an initial collaboration that began in 2025 and mirrors the integrated clinical model Weight Watchers offers in the United States. The announcement comes as WW International faces financial headwinds, with its stock declining 31% over the past six months and revenue decreasing 9.61% over the last twelve months.Stock TitanWeight Watchers, CheqUp widen UK weight-loss tie-upWW International (Weight Watchers) and UK-based CheqUp announced on June 16, 2026, a significant expansion of their existing partnership to deliver integrated behavioral and clinical weight management support to UK members. The two-way partnership allows Weight Watchers members to access CheqUp's medical weight loss programme and CheqUp members to use the Weight Watchers app and GLP-1 Companion Programme. The expansion aligns with the NHS's recent expansion of GLP-1 medication access to over a million people in England with heart health issues.GlobeNewswireWeight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UKWeight Watchers (WW International, Inc.) and CheqUp announced a significant expansion of their partnership in the UK on June 16, 2026, creating a two-way integration that allows Weight Watchers members to access CheqUp's medical weight loss programme while CheqUp members gain full access to Weight Watchers' app and behavioural programmes. The expanded partnership builds on their initial 2025 collaboration and aligns with the NHS's recent expansion of weight-loss medication access to over a million people in England. The companies emphasized that sustainable weight health requires clinical oversight, behaviour change, and health marker tracking working together, with 85% of U.S. GLP-1 Companion Programme members reporting that Weight Watchers makes it easier to get healthy.The DrumHow WeightWatchers tipped the scales with a GLP-1 pivotWeightWatchers, now rebranded as WW, has partnered with CheqUp to integrate GLP-1 pharmaceutical treatments into its wellness offerings. This strategic pivot aims to leverage the company's existing member base and points-based system to address weight management through medication alongside traditional lifestyle programs.NotltdWeightWatchers pivots from diets to drugs in UK partnership with anti-obesity treatment provider CheqUpWeightWatchers has entered a strategic partnership in the UK with CheqUp to provide its app-based lifestyle support to patients using GLP-1 weight-loss medications. This pivot follows WeightWatchers' Chapter 11 bankruptcy filing in the US, driven by declining membership as consumers shift toward pharmaceutical treatments for obesity. The collaboration aims to enhance sustainable weight loss outcomes by combining medication with nutritional and behavioural guidance.MarketScreenerCheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UKCheqUp and WeightWatchers announced a strategic partnership in the UK to combine clinical support with nutritional programs for patients using GLP-1 weight loss medications. This collaboration aims to address the growing demand among the 12 million UK residents qualifying for these prescriptions by offering a holistic care model. The initiative coincides with government examination of wider GLP-1 medication rollouts to improve health outcomes and work productivity.